Safety and Immunogenicity Dose-finding Study of Adjuvanted SCB-2020S Vaccine in Adults (clinicaltrials.gov) - Jul 3, 2023 - P1 | N=153 | Completed | Sponsor: Clover Biopharmaceuticals AUS Pty Ltd | Active, not recruiting ➔ Completed | Trial completion date: Sep 2023 ➔ Apr 2023 | Trial primary completion date: Sep 2023 ➔ Sep 2022
Trial completion • Trial completion date • Trial primary completion date • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
|